WaferGen Bio-Systems (WGBS) Misses Q2 EPS by 8c; Trims FY16 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. AXP
9. TMUS
10. SPY

Go back to WaferGen Bio-Systems (WGBS) Misses Q2 EPS by 8c; Trims FY16 Revenue Outlook

WaferGen Bio-systems Reports Results for Second Quarter 2016

August 9, 2016 4:02 PM EDT

FREMONT, Calif., Aug. 9, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a life sciences company focused on developing and commercializing technology platforms for genomic solutions, announced today its financial results for the second quarter ended June 30, 2016.

Key Recent Highlights

Announced in May 2016 the proposed merger with Takara Bio USA Holdings Inc. and certain of its affiliates, pursuant to which Takara would acquire the Company for a multiple of the Company's 2016 revenue, subject to certain... More